GPT Healthcare Q1FY27: standalone PAT +65.7% YoY on margin expansion, revenue up 17.8%

GPT Healthcare's standalone revenue from operations rose 17.8% YoY to ₹126.20 Cr (Q1FY26: ₹107.11 Cr), while PAT climbed 65.7% YoY to ₹12.73 Cr (Q1FY26: ₹7.68 Cr) on basic EPS of ₹1.55 versus ₹0.94. Sequentially revenue was flat (-0.1% QoQ vs ₹126.37 Cr in Q4FY26), but PAT fell 12.6% QoQ from ₹14.57 Cr — a tax-driven dip, not an operating one: PBT actually grew 8.2% QoQ to ₹17.16 Cr, but Q4FY26's effective tax rate was an unusually low ~8.2% (helped by a ~₹3.50 Cr deferred-tax credit) against this quarter's normalized ~25.8% rate. Operating margin (EBITDA/revenue, computed as PBT less other income plus depreciation and finance costs, over revenue) expanded to 19.16% from 16.21% a year ago and 18.49% last quarter, pointing to genuine operating leverage as cost lines (materials, employee expense) grew slower than revenue. Net margin (PAT/total income) improved YoY to 9.93% from 7.07%, though it read lower than Q4FY26's 11.38% purely because of the tax-base effect described above. Management's FY27 guidance (from the Q4FY26 concall) called for 15% YoY revenue growth, ~8% ARPOB growth, and a step-up to ~20.2% EBITDA margin for the full year, alongside Raipur hospital reaching monthly breakeven by Q3FY27 (~30% occupancy by year-end) and a ~150-bed Jamshedpur addition by Q4FY27. Q1's 17.8% YoY revenue growth already runs ahead of the 15% annual guidance pace, and the 19.16% OPM is progressing toward, though still short of, the 20.2% full-year target — consistent with management's own outlook rather than contradicting it. The filing discloses only one reportable segment (healthcare services in India, Note 3), so hospital-level Raipur/Jamshedpur progress cannot be independently verified from these numbers. No management press release was available in the context to cross-check messaging, and no broker/consensus estimates for this quarter could be located in a web search, so the print cannot be benchmarked against street numbers this quarter. Corporate developments this quarter were administrative — the board approved results at today's meeting, following the trading-window closure on June 27 and the July 9 dispatch of the AGM notice along with a ₹1.50/share final FY26 dividend — none of which bear on the operating print.